NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) PT Set at C$5.50 by Royal Bank Of Canada

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) has been given a C$5.50 price objective by equities researchers at Royal Bank Of Canada in a report released on Monday,BayStreet.CA reports. The brokerage presently has a “sector perform” rating on the stock. Royal Bank Of Canada’s target price indicates a potential upside of 2.04% from the stock’s current price.

A number of other equities research analysts have also commented on NWH.UN. BMO Capital Markets increased their price target on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a research report on Thursday, November 13th. Scotiabank upped their price objective on shares of NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a research report on Thursday, November 13th. Finally, CIBC upped their target price on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a report on Thursday, November 13th. One equities research analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of C$6.00.

NorthWest Health Prop Real Est Inv Trust Stock Up 2.3%

Shares of TSE NWH.UN traded up C$0.12 during midday trading on Monday, hitting C$5.39. 505,936 shares of the stock traded hands, compared to its average volume of 595,723. The company has a debt-to-equity ratio of 129.42, a quick ratio of 0.06 and a current ratio of 0.25. NorthWest Health Prop Real Est Inv Trust has a one year low of C$4.33 and a one year high of C$5.73. The business has a 50 day moving average price of C$5.13 and a two-hundred day moving average price of C$4.98. The company has a market cap of C$1.34 billion, a PE ratio of 26.66, a P/E/G ratio of 0.74 and a beta of 1.46.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) last announced its quarterly earnings results on Tuesday, November 11th. The company reported C$0.06 EPS for the quarter. The business had revenue of C$110.69 million during the quarter. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative return on equity of 14.67%. On average, equities analysts predict that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 EPS for the current year.

NorthWest Health Prop Real Est Inv Trust Company Profile

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.